tiprankstipranks
pc:prama

Pramana Pharmaceuticals Inc

Therapeutics
Pramana Pharmaceuticals Inc. is a near-term clinical-stage biotechnology company developing next-generation oral small-molecule therapies targeting metabolic signaling pathways across neurodegenerative and cardio-metabolic diseases. Its lead program, PRM-914, is a first-in-class oral GPR119 agonist advancing toward the clinic for Alzheimer's disease, supported by a wholly owned global composition-of-matter IP estate.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$1M
Total Amount Raised$1M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$1M
Latest Funding Amount$1M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2026
Investment
$1.00M
―

Investors

Investor Name
Funding Round
Alzheimer's Association
Investment

Related News and Analysis

FloodMapp Gains Visibility With Queensland Flood-Alert Deployment and Media Coverage

FloodMapp Gains Visibility With Queensland Flood-Alert Deployment and Media Coverage

According to a recent LinkedIn post from FloodMapp, the company’s work on flood resilience has been featured in...
1h ago
FLO2W
Raspberry AI Promotes Weekly Studio Sessions to Drive Engagement With AI Design Workflow

Raspberry AI Promotes Weekly Studio Sessions to Drive Engagement With AI Design Workflow

According to a recent LinkedIn post from Raspberry AI, the company is inviting users to weekly Raspberry AI...
1h ago
RASPB
Jupiter Intelligence Highlights Climate Risk Inflection Points and Adaptation ROI

Jupiter Intelligence Highlights Climate Risk Inflection Points and Adaptation ROI

According to a recent LinkedIn post from Jupiter Intelligence, the company is emphasizing how physical climate risks can...
1h ago
JUP5G
Truveta Research Highlights Rising Use of Estrogen-Based Hormone Therapy

Truveta Research Highlights Rising Use of Estrogen-Based Hormone Therapy

According to a recent LinkedIn post from Truveta, new analysis from Truveta Research suggests that estrogen-based hormone replacement...
1h ago
TRVTA
Media Coverage Underscores Celonis Positioning in Process Intelligence and AI

Media Coverage Underscores Celonis Positioning in Process Intelligence and AI

A LinkedIn post from Celonis highlights a cluster of recent media coverage positioning the company at the intersection...
1h ago
CLONS
Sifflet Promotes Self-Serve Trial to Drive Product-Led Growth in Data Observability

Sifflet Promotes Self-Serve Trial to Drive Product-Led Growth in Data Observability

According to a recent LinkedIn post from Sifflet, the company is positioning its platform as a tool to...
1h ago
SIFFL
Everstage Highlights Data Discipline as Key to Effective AI Adoption in Sales Workflows

Everstage Highlights Data Discipline as Key to Effective AI Adoption in Sales Workflows

According to a recent LinkedIn post from Everstage, a joint session featuring Zoë Mckenzie of Checkr, Inc. and...
1h ago
EVE6A
Axtria Targets Pharma Europe 2026 Forum to Deepen Life Sciences Engagement

Axtria Targets Pharma Europe 2026 Forum to Deepen Life Sciences Engagement

According to a recent LinkedIn post from Axtria, the company plans to participate in Reuters Events Pharma Europe...
1h ago
AXTRI
Andelyn Biosciences Highlights Collaborative CDMO Model With OneTeam Webinar

Andelyn Biosciences Highlights Collaborative CDMO Model With OneTeam Webinar

According to a recent LinkedIn post from Andelyn Biosciences, the company is promoting an April 15 webinar focused...
1h ago
AND3Y
Qualytics Targets AI Data Risk With New Pre-Decision Control Layer

Qualytics Targets AI Data Risk With New Pre-Decision Control Layer

According to a recent LinkedIn post from Qualytics, the company is introducing a “Data Control Layer,” described as...
1h ago
QUALY